Author:
Böttcher Sebastian,Ritgen Matthias,Dreger Peter
Reference47 articles.
1. How I Treat Refractory CLL;Montserrat;Blood,2006
2. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia;Tam;Blood,2008
3. First-line treatment with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) versus fludarabine and cyclophosphamide (FC) improves overall survival (PFS) of previously untreated patients (pts) with advanced chronic lymphocytic leukemia (CLL) [abstract];Hallek;Blood (ASH Annual Meeting Abstracts),2009
4. Treatment of fludarabine-refractory chronic lymphocytic leukemia;Tsimberidou;Cancer,2009
5. Genomic aberrations and survival in chronic lymphocytic leukemia;Döhner;N Engl J Med,2000
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献